Oxford BioMedica Company
25+ years enabling the world’s most progressive and successful viral vector therapies. Full service offering, supported by robust quality systems.
Total Funding:
£12.3M
Headquarters:
Oxford, Oxfordshire, United Kingdom
Funding Status:
M&A
Employee Number:
51-100
Estimated Revenue:
$10M to $50M
Investment Stage:
N/A
Last Funding Type:
Grant
Number Of Exists:
Grant
Technology:
Others
Investor Type:
Company
Investors Number:
1
Founded Date:
1995
Industry:
Gene Therapy